Insiders · Profile

Sigma Emerging Markets Ltd.

10% owner at Rein Therapeutics. Filing since 5 Jul 2017. CIK 0001709926

Company

Date

Role

Action

Shares

Amount

Of holding

RNTX Rein Therapeutics, Inc.

5 Jul 2017

10% owner

Bought

190,000

$2.85M

81.5%

1 decision on file.